Winther J, Overgaard J
Department of Ophthalmology, Aarhus University Hospital, Denmark.
Acta Ophthalmol (Copenh). 1989 Feb;67(1):44-50. doi: 10.1111/j.1755-3768.1989.tb00721.x.
The destructive effect on tumour tissue and on normal eye tissue of photodynamic therapy has been investigated in rat eyes containing fast growing retinoblastoma-like tumours. Tumour response was described in terms of local control 90 days after treatment. The curability increased up to a maximum when large Photofrin II doses or light energy doses were administered. Early damage of conjunctiva or cornea also increased with large treatment doses and was an important limitation factor for improvement of the curability in the current model. The level of normal tissue damage decreased rapidly with increasing intervals between administration of Photofrin II and light, suggesting that conjunctival or corneal damage may not be a limitation factor 3-5 days after Photofrin II administration. A reciprocal relationship between light energy doses and Photofrin II doses was demonstrated both for curability and for the normal tissue damage. The results suggested that 2.5 mg/kg Photofrin II in combination with an extended light irradiation provoked less normal tissue damage than 10 mg/kg Photofrin II in combination with an equivalent shorter light exposure in order to obtain 15% curability of the animals.
在患有快速生长的视网膜母细胞瘤样肿瘤的大鼠眼中,研究了光动力疗法对肿瘤组织和正常眼组织的破坏作用。根据治疗90天后的局部控制情况描述肿瘤反应。当给予大剂量的光敏剂II或光能剂量时,治愈率会增加到最大值。大剂量治疗时,结膜或角膜的早期损伤也会增加,这是当前模型中提高治愈率的一个重要限制因素。随着光敏剂II给药与光照之间间隔时间的增加,正常组织损伤水平迅速下降,这表明在光敏剂II给药后3 - 5天,结膜或角膜损伤可能不是限制因素。对于治愈率和正常组织损伤,都证明了光能剂量与光敏剂II剂量之间存在反比关系。结果表明,为了使动物获得15%的治愈率,与等效的较短光照时间联合使用10mg/kg光敏剂II相比,联合使用2.5mg/kg光敏剂II并延长光照时间会引起较少的正常组织损伤。